Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$2.85 - $7.77 $1.79 Million - $4.88 Million
-627,759 Closed
0 $0
Q1 2022

Apr 27, 2022

BUY
$5.7 - $9.3 $113,407 - $185,032
19,896 Added 3.27%
627,759 $4.77 Million
Q4 2021

Feb 02, 2022

SELL
$8.73 - $15.27 $45,570 - $79,709
-5,220 Reduced 0.85%
607,863 $5.29 Million
Q3 2021

Oct 25, 2021

SELL
$13.52 - $23.95 $88,596 - $156,944
-6,553 Reduced 1.06%
613,083 $8.48 Million
Q2 2021

Aug 02, 2021

SELL
$22.12 - $32.06 $3.59 Million - $5.21 Million
-162,485 Reduced 20.77%
619,636 $15 Million
Q1 2021

Apr 30, 2021

BUY
$26.12 - $52.17 $3.23 Million - $6.46 Million
123,768 Added 18.8%
782,121 $25.1 Million
Q4 2020

Feb 05, 2021

SELL
$14.05 - $29.0 $1.7 Million - $3.52 Million
-121,282 Reduced 15.56%
658,353 $16.1 Million
Q3 2020

Oct 30, 2020

SELL
$14.17 - $19.48 $130,052 - $178,787
-9,178 Reduced 1.16%
779,635 $11.2 Million
Q2 2020

Jul 27, 2020

BUY
$13.25 - $21.72 $385,164 - $631,378
29,069 Added 3.83%
788,813 $12.7 Million
Q1 2020

Apr 27, 2020

BUY
$9.73 - $24.9 $104,120 - $266,454
10,701 Added 1.43%
759,744 $11 Million
Q4 2019

Jan 31, 2020

SELL
$14.22 - $23.38 $248,352 - $408,331
-17,465 Reduced 2.28%
749,043 $15.8 Million
Q3 2019

Oct 31, 2019

SELL
$22.93 - $41.06 $229,987 - $411,831
-10,030 Reduced 1.29%
766,508 $17.6 Million
Q2 2019

Jul 29, 2019

SELL
$38.73 - $52.03 $1.74 Million - $2.33 Million
-44,844 Reduced 5.46%
776,538 $31.4 Million
Q1 2019

May 08, 2019

BUY
$28.11 - $50.77 $4.2 Million - $7.58 Million
149,334 Added 22.22%
821,382 $35.5 Million
Q4 2018

Feb 06, 2019

BUY
$26.22 - $56.89 $17.6 Million - $38.2 Million
672,048 New
672,048 $18.4 Million

Others Institutions Holding CGC

About Canopy Growth Corp


  • Ticker CGC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 480,284,000
  • Market Cap $1.05B
  • Description
  • Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include d...
More about CGC
Track This Portfolio

Track Sumitomo Mitsui Trust Holdings, Inc. Portfolio

Follow Sumitomo Mitsui Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.